271 related articles for article (PubMed ID: 23421569)
1. Resisting the urge to smoke and craving during a smoking quit attempt on varenicline: results from a pilot fMRI study.
Hartwell KJ; Lematty T; McRae-Clark AL; Gray KM; George MS; Brady KT
Am J Drug Alcohol Abuse; 2013 Mar; 39(2):92-8. PubMed ID: 23421569
[TBL] [Abstract][Full Text] [Related]
2. Effects of varenicline on smoking cue–triggered neural and craving responses.
Franklin T; Wang Z; Suh JJ; Hazan R; Cruz J; Li Y; Goldman M; Detre JA; O'Brien CP; Childress AR
Arch Gen Psychiatry; 2011 May; 68(5):516-26. PubMed ID: 21199958
[TBL] [Abstract][Full Text] [Related]
3. The effects of varenicline on stress-induced and cue-induced craving for cigarettes.
Ray LA; Lunny K; Bujarski S; Moallem N; Krull JL; Miotto K
Drug Alcohol Depend; 2013 Jul; 131(1-2):136-42. PubMed ID: 23298651
[TBL] [Abstract][Full Text] [Related]
4. Neural correlates of craving and resisting craving for tobacco in nicotine dependent smokers.
Hartwell KJ; Johnson KA; Li X; Myrick H; LeMatty T; George MS; Brady KT
Addict Biol; 2011 Oct; 16(4):654-66. PubMed ID: 21790899
[TBL] [Abstract][Full Text] [Related]
5. Effect of varenicline and bupropion SR on craving, nicotine withdrawal symptoms, and rewarding effects of smoking during a quit attempt.
West R; Baker CL; Cappelleri JC; Bushmakin AG
Psychopharmacology (Berl); 2008 Apr; 197(3):371-7. PubMed ID: 18084743
[TBL] [Abstract][Full Text] [Related]
6. Impact of varenicline on cue-specific craving assessed in the natural environment among treatment-seeking smokers.
Gass JC; Wray JM; Hawk LW; Mahoney MC; Tiffany ST
Psychopharmacology (Berl); 2012 Sep; 223(1):107-16. PubMed ID: 22476610
[TBL] [Abstract][Full Text] [Related]
7. The impact of three weeks of pre-quit varenicline on reinforcing value and craving for cigarettes in a laboratory choice procedure.
Lawson SC; Gass JC; Cooper RK; Tonkin SS; Colder CR; Mahoney MC; Tiffany ST; Hawk LW
Psychopharmacology (Berl); 2021 Feb; 238(2):599-609. PubMed ID: 33219852
[TBL] [Abstract][Full Text] [Related]
8. Effects of varenicline and cognitive bias modification on neural response to smoking-related cues: study protocol for a randomized controlled study.
Attwood AS; Williams T; Adams S; McClernon FJ; Munafò MR
Trials; 2014 Oct; 15():391. PubMed ID: 25294104
[TBL] [Abstract][Full Text] [Related]
9. The fMRI BOLD response to unisensory and multisensory smoking cues in nicotine-dependent adults.
Cortese BM; Uhde TW; Brady KT; McClernon FJ; Yang QX; Collins HR; LeMatty T; Hartwell KJ
Psychiatry Res; 2015 Dec; 234(3):321-7. PubMed ID: 26475784
[TBL] [Abstract][Full Text] [Related]
10. Brain activation patterns associated with cue reactivity and craving in abstinent problem gamblers, heavy smokers and healthy controls: an fMRI study.
Goudriaan AE; de Ruiter MB; van den Brink W; Oosterlaan J; Veltman DJ
Addict Biol; 2010 Oct; 15(4):491-503. PubMed ID: 20840335
[TBL] [Abstract][Full Text] [Related]
11. Varenicline: a first-line treatment option for smoking cessation.
Garrison GD; Dugan SE
Clin Ther; 2009 Mar; 31(3):463-91. PubMed ID: 19393839
[TBL] [Abstract][Full Text] [Related]
12. Varenicline effects on drinking, craving and neural reward processing among non-treatment-seeking alcohol-dependent individuals.
Schacht JP; Anton RF; Randall PK; Li X; Henderson S; Myrick H
Psychopharmacology (Berl); 2014 Sep; 231(18):3799-807. PubMed ID: 24647921
[TBL] [Abstract][Full Text] [Related]
13. Effects of 21 days of varenicline versus placebo on smoking behaviors and urges among non-treatment seeking smokers.
Ashare RL; Tang KZ; Mesaros AC; Blair IA; Leone F; Strasser AA
J Psychopharmacol; 2012 Oct; 26(10):1383-90. PubMed ID: 22695488
[TBL] [Abstract][Full Text] [Related]
14. The effects of extended pre-quit varenicline treatment on smoking behavior and short-term abstinence: a randomized clinical trial.
Hawk LW; Ashare RL; Lohnes SF; Schlienz NJ; Rhodes JD; Tiffany ST; Gass JC; Cummings KM; Mahoney MC
Clin Pharmacol Ther; 2012 Feb; 91(2):172-80. PubMed ID: 22130118
[TBL] [Abstract][Full Text] [Related]
15. A preliminary investigation of varenicline for heavy drinking smokers.
Fucito LM; Toll BA; Wu R; Romano DM; Tek E; O'Malley SS
Psychopharmacology (Berl); 2011 Jun; 215(4):655-63. PubMed ID: 21221531
[TBL] [Abstract][Full Text] [Related]
16. Gender difference and effect of pharmacotherapy: findings from a smoking cessation service.
Walker NJ; van Woerden HC; Kiparoglou V; Yang Y; Robinson H; Croghan E
BMC Public Health; 2016 Oct; 16(1):1038. PubMed ID: 27716223
[TBL] [Abstract][Full Text] [Related]
17. Varenicline decreases alcohol consumption in heavy-drinking smokers.
Mitchell JM; Teague CH; Kayser AS; Bartlett SE; Fields HL
Psychopharmacology (Berl); 2012 Oct; 223(3):299-306. PubMed ID: 22547331
[TBL] [Abstract][Full Text] [Related]
18. Dissociable effect of acute varenicline on tonic versus cue-provoked craving in non-treatment-motivated heavy smokers.
Hitsman B; Hogarth L; Tseng LJ; Teige JC; Shadel WG; DiBenedetti DB; Danto S; Lee TC; Price LH; Niaura R
Drug Alcohol Depend; 2013 Jun; 130(1-3):135-41. PubMed ID: 23201174
[TBL] [Abstract][Full Text] [Related]
19. Neural substrates of resisting craving during cigarette cue exposure.
Brody AL; Mandelkern MA; Olmstead RE; Jou J; Tiongson E; Allen V; Scheibal D; London ED; Monterosso JR; Tiffany ST; Korb A; Gan JJ; Cohen MS
Biol Psychiatry; 2007 Sep; 62(6):642-51. PubMed ID: 17217932
[TBL] [Abstract][Full Text] [Related]
20. Effect of varenicline on aspects of inhibitory control in smokers.
Austin AJ; Duka T; Rusted J; Jackson A
Psychopharmacology (Berl); 2014 Sep; 231(18):3771-85. PubMed ID: 24652107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
